Ecosprin AV (150/20) mg Capsule

Ecosprin AV (150/20) mg Capsule is a doctor prescribed anti platelet agent that prevent blood clots, reducing risks of heart attacks, strokes, and angina in patients with cardiovascular conditions. Ecosprin AV (150/20) mg Capsule contains 150mg of Aspirin and 20mg atorvastatin that prevent platelet aggregation and reduce blood clot formation.

Prevent Blood Clots

Ecosprin AV (150/20) mg Capsule is an allopathic medication that can only be purchased with a prescription. This is a component of a chemical based medication. Like any other chemical-based drug, its chemical-based formula causes multiple negative effects. See your physician if these side effects persist for an extended period of time.
● Heat Burn
● Nausea
● Stomach Upset
● Abdominal pain
● Increased Bleeding Risk
● Gastrointestinal Bleeding
● Severe Allergic Reactions
● Reye's Syndrome
● Hemorrhagic Stroke
● Rhabdomyolysis (muscle breakdown)
● Severe liver injury (jaundice, dark urine)
● Gastrointestinal bleeding/perforation
● Severe allergic reactions (anaphylaxis)
● Myopathy

Ecosprin AV (150/20) mg Capsule is taken orally. Tablet is swallowed as it is with the help of water. It can be taken after or before food consumption (Prefer After Food). Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy. In general,Ecosprin AV (150/20) mg Capsule dosage in just one tablet at same time every day. For more personalized assistance and exact dosage, talk to your doctor about the same.

Ecosprin AV 150/20 mg Capsule functions in two ways: atorvastatin (20 mg) competitively inhibits HMG-CoA reductase in the liver to reduce cholesterol biosynthesis, lowering LDL/triglycerides and stabilising plaques, while aspirin (150 mg) irreversibly inhibits platelet COX-1 via acetylation to block thromboxane A2 synthesis and prevent aggregation/clot formation.

• Hebert, P. R., Pfeffer, M. A., & Hennekens, C. H. (2002). Use of statins and aspirin to reduce risks of cardiovascular disease. Journal of cardiovascular pharmacology and therapeutics, 7(2), 77-80.
• Tippabhotla, S. K., Betha, M. R., Gadiko, C., Battula, R., Nakkawar, M., Cheerla, R., ... & Vobalaboina, V. (2013). Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: A randomized, open-label, single-dose, two-way crossover study in healthy human subjects. Drug research, 63(05), 250-257.
• Farid, N. A., Small, D. S., Payne, C. D., Jakubowski, J. A., Brandt, J. T., Li, Y. G., ... & Winters, K. J. (2008). Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 28(12), 1483-1493.
• Hirsh, J., Dalen, J. E., Fuster, V., Harker, L. B., Patrono, C., & Roth, G. (1995). Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects. Chest, 108(4), 247S-257S.